ERBB2 and neoplasm: Furthermore, cytotoxicity experiments at various effector-to-target (E:T) ratios demonstrated that both CAR and CAR-shSIRPα macrophages had significant dose-dependent killing effects on HER2-positive tumor cells (Fig. 3H and Supplementary Fig. 5a–d).